论文部分内容阅读
目的对比探讨伊贝沙坦与卡托普利治疗老年慢性心力衰竭的方法及疗效。方法随机抽取大连市大化集团有限责任公司医院收治的90例老年慢性心力衰竭患者,自愿分为2组,对照组42例行卡托普利治疗,实验组48例行伊贝沙坦治疗。随访1～2个月,比较两组患者的临床疗效。结果两组间相比,治疗后实验组患者的总有效率为93.7%,高于对照组的78.5%,差异有统计学意义(P<0.05)。结论应用伊贝沙坦治疗老年慢性心力衰竭,可显著提高临床疗效,改善患者的生活质量。
Objective To compare and explore the method and efficacy of irbesartan and captopril in the treatment of senile chronic heart failure. Methods Ninety elderly patients with chronic heart failure were randomly selected from two hospitals in Dahua Group Co., Ltd., Dalian. 42 patients in the control group were treated with captopril, and 48 in the experimental group were treated with irbesartan. Follow-up 1 to 2 months, the clinical efficacy of two groups were compared. Results The total effective rate of the experimental group after treatment was 93.7%, which was higher than that of the control group (78.5%), the difference was statistically significant (P <0.05). Conclusion The application of irbesartan in elderly patients with chronic heart failure can significantly improve the clinical efficacy and improve the quality of life of patients.